DOI: 10.1128/AAC.01196-19
Article Information
PubMed
Published By
History
- Received June 12, 2019
- Returned for modification July 28, 2019
- Accepted October 8, 2019
- Published online December 20, 2019.
Copyright & Usage
Copyright © 2019 American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (October 21, 2019).
- You are viewing the most recent version of this article.
Author Information
- Nathalie Saint-Lua,
- Charles Burdetb,c,
- Frédérique Sablier-Gallisa,
- Tanguy Corbela,
- Agathe Nevièrea,
- Sakina Sayah-Jeannea,
- Mark Pulsed,
- William Weissd,
- Stéphanie Ferreirae,
- Antoine Andremontb,
- France Mentréb,c and
- Jean de Gunzburga
- aDa Volterra, Paris, France
- bUniversité de Paris, IAME, INSERM, Paris, France
- cAP-HP, Bichat Hospital, Department of Epidemiology, Biostatistics, and Clinical Research, Paris, France
- dUNT Health Science Center, Fort Worth, Texas, USA
- eGenoScreen, Lille, France
- Address correspondence to Jean de Gunzburg, gunzburg{at}davolterra.com.
Citation Saint-Lu N, Burdet C, Sablier-Gallis F, Corbel T, Nevière A, Sayah-Jeanne S, Pulse M, Weiss W, Ferreira S, Andremont A, Mentré F, de Gunzburg J. 2020. DAV131A protects hamsters from lethal Clostridioides difficile infection induced by fluoroquinolones. Antimicrob Agents Chemother 64:e01196-19. https://doi.org/10.1128/AAC.01196-19.
